Damora Therapeutics, Inc. financial statements
Damora Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 209.84M | 10-K |
| Cash and equivalents | USD 257.62M | 10-Q |
| Total debt | USD 68K | EODHD |
Damora Therapeutics, Inc. financials on 6ix · Damora Therapeutics, Inc. on 6ix